Armbruster Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$399K Hold
2,152
0.07% 98
2025
Q1
$451K Hold
2,152
0.09% 90
2024
Q4
$382K Hold
2,152
0.08% 97
2024
Q3
$425K Buy
2,152
+132
+7% +$26.1K 0.08% 94
2024
Q2
$346K Buy
2,020
+122
+6% +$20.9K 0.07% 95
2024
Q1
$346K Hold
1,898
0.07% 88
2023
Q4
$294K Hold
1,898
0.07% 91
2023
Q3
$283K Hold
1,898
0.07% 88
2023
Q2
$256K Buy
1,898
+488
+35% +$65.7K 0.06% 95
2023
Q1
$225K Hold
1,410
0.06% 99
2022
Q4
$228K Buy
+1,410
New +$228K 0.06% 98
2022
Q3
Sell
-1,410
Closed -$216K 106
2022
Q2
$216K Hold
1,410
0.06% 108
2022
Q1
$229K Buy
+1,410
New +$229K 0.06% 118
2018
Q2
Sell
-600
Closed -$57K 70
2018
Q1
$57K Sell
600
-74
-11% -$7.03K 0.03% 122
2017
Q4
$65K Hold
674
0.03% 113
2017
Q3
$60K Sell
674
-354
-34% -$31.5K 0.03% 115
2017
Q2
$75K Buy
1,028
+65
+7% +$4.74K 0.04% 107
2017
Q1
$63K Sell
963
-100
-9% -$6.54K 0.04% 115
2016
Q4
$67K Hold
1,063
0.04% 112
2016
Q3
$67K Hold
1,063
0.04% 107
2016
Q2
$66K Hold
1,063
0.04% 107
2016
Q1
$61K Hold
1,063
0.04% 111
2015
Q4
$63K Buy
+1,063
New +$63K 0.06% 114